سعر ايزوجاست 40مجم 14 كبسولة 2024

Esomeprazole 40 mg delayed-release capsules (Ezogast; Copad Pharma), pack of 14 capsules.

• Short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis in adults; maintenance of healing of erosive esophagitis.Population: AdultsDailyMed (U.S. National Library of Medicine)
• Treatment of symptomatic gastroesophageal reflux disease (GERD).Population: AdultsDailyMed (U.S. National Library of Medicine)
• Risk reduction of NSAID-associated gastric ulcer in at-risk patients receiving continuous NSAID therapy.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions in adults (>=1%): headache, diarrhea, nausea, flatulence, abdominal pain, constipation and dry mouth.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to substituted benzimidazoles or any component of the formulation.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant use with rilpivirine-containing products.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Symptomatic response does not preclude gastric malignancy; consider further evaluation in adults with suboptimal response or early relapse.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Acute tubulointerstitial nephritis: discontinue and evaluate if suspected.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• PPI therapy may be associated with increased risk of Clostridioides difficile-associated diarrhea.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• RilpivirineAvoidContraindicated: decreased rilpivirine exposure and possible loss of virologic response.DailyMed (U.S. National Library of Medicine)
• ClopidogrelAvoidReduced exposure to the active metabolite of clopidogrel; avoid concomitant use.DailyMed (U.S. National Library of Medicine)

• There are no adequate and well-controlled studies with esomeprazole in pregnant women; available epidemiologic data with omeprazole (racemic) did not show an increased risk of major malformations.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Limited data: esomeprazole (as omeprazole) is present in human milk; consider benefits of breastfeeding with the mother's need for the drug.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Esomeprazole: Suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell (US Nexium label).